PEGBIO CO-B (02565.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec22

Pg Bio-Pharmaceutical-B Completes Placement Agreement

13:02

Dec14

Parexel Biopharmaceutical-B's cornerstone investors extend lock-up period

23:20

Pegasus Biopharmaceuticals-B Places 5.136 Million Shares to Raise HK$300 Million

11:38

Nov27

Pega Biopharma-B Secures Anchor Investor Lock-Up Commitment

00:36

Nov26

SoftBank China Capital Reiterates Buy Rating on Pega Biopharma-B

05:06

Nov17

Pegbio-B's Core Product PB-119 Approved for Marketing by NMPA

01:35

Schedules & Filings

Schedules

Filings

Aug26

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Net Income -51.23 M, EPS -0.1383

May27

IPO(CST)

Listing Price HKD 15.6

May18

Earning Release(CST)

FY2024 Annual Earning Release (HKD) Net Income -306.51 M, EPS -0.8359

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More